DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Alnylam Pharmaceuticals, Inc. (ALNY)
« Back to company indexALNY Chatter Timeline
Stock Ticker for ALNY
Most Active Tweeters for ALNY
No tweets foundRecent Tweets for ALNY
 |
@MaisaCorp $ALNY Completes Enrollment In Envision Phase 3 Study Of Givosiran- ON TRACK TO REPORT INTERIM ANALYSIS DATA BY END… https://t.co/Cg3dnb3u8h August 21st 2018, 7:08pm |
 |
@MareaInformativ Goldman Sachs Group Lowers Alnylam Pharmaceuticals $ALNY to Buy https://t.co/VQMJJEkOlX August 21st 2018, 5:08pm |
 |
@dakotafinancial Analysts Set Alnylam Pharmaceuticals, Inc. $ALNY Target Price at $142.00 https://t.co/yyuSTorN8T August 21st 2018, 3:08pm |
 |
@bibeypost_stock It Seems Alnylam Pharmaceuticals, Inc. $ALNY Will Go Down. Formed A Few Months Double Bottom Chart Pattern - https://t.co/ArdipA6hEz August 21st 2018, 3:08pm |
 |
@reurope_stock Alnylam Pharmaceuticals, Inc. $ALNY Could Burn Your Portfolio. The Stock Formed Bearish Double Bottom Chart Pattern https://t.co/zew5v82vRg August 21st 2018, 3:08pm |
 |
@mmahotstuff1 What's in Alnylam Pharmaceuticals, Inc. $ALNY After Forming Bearish Double Bottom Chart Pattern? - https://t.co/fLqRubLu1z August 21st 2018, 3:08pm |
 |
@whatsonthorold2 It Seems Alnylam Pharmaceuticals, Inc. $ALNY Will Go Down. Formed A Few Months Bearish Double Bottom Chart Pattern - https://t.co/r9R1ioyOyr August 21st 2018, 3:08pm |
 |
@west_moreland Does Alnylam Pharmaceuticals, Inc. $ALNY Have Any Gas After Forming This Double Bottom Chart Pattern? https://t.co/g69PTCU5sH August 21st 2018, 3:08pm |
 |
@Fanob_stock Could Alnylam Pharmaceuticals, Inc. $ALNY See a Reversal After Having Formed Several Months Double Bottom https://t.co/GWV49VyJOO August 21st 2018, 3:08pm |
 |
@usindexlive Lord Abbett & Company Increases Holding in Alnylam Pharmaceuticals Com $ALNY; Grupo Aeroportuario Ctr Nort $OMAB St… https://t.co/uI9pFiy4CS August 21st 2018, 3:08pm |
 |
@EnterpriseLeade Morgan Stanley Analysts Give Alnylam Pharmaceuticals $ALNY a $93.00 Price Target https://t.co/AHj8bGEjbO August 21st 2018, 3:08pm |
|
@MareaInformativ Stifel Nicolaus Reaffirms Buy Rating for Alnylam Pharmaceuticals $ALNY https://t.co/e2hNlUsJsx August 21st 2018, 2:08pm |
 |
@Singlemalt_18 12 month return for $IONS and $ALNY a virtual tie at +12.5% vs +14% How's that 80/20 advantage for patirisan vs inotersen workin' out? August 21st 2018, 1:08pm |
 |
@MarketCurrents Alnylam competes enrollment in late-stage study of givosiran in AHP https://t.co/OTiV8tn8lH #premarket $ALNY August 21st 2018, 11:08am |
 |
@Amarshall7M RT @odibro: $ALNY Completes Enrollment in ENVISION P3 Study of Givosiran, an Investigational RNAi Therapeutic for the Treatment of AHPs. In… August 21st 2018, 11:08am |
 |
@tabuhasna RT @BioStocks: $ALNY completes Enrollment in ENVISION Phase 3 Study of Givosiran for the Treatment of Acute Hepatic Porphyrias (AHPs). Int… August 21st 2018, 11:08am |
 |
@odibro $ALNY Completes Enrollment in ENVISION P3 Study of Givosiran, an Investigational RNAi Therapeutic for the Treatment… https://t.co/bLyIXLH9I6 August 21st 2018, 11:08am |
 |
@BioStocks $ALNY completes Enrollment in ENVISION Phase 3 Study of Givosiran for the Treatment of Acute Hepatic Porphyrias (AH… https://t.co/7eauBlsPqP August 21st 2018, 11:08am |
 |
@tt300z $ALNY - Alnylam Completes Enrollment in ENVISION Phase 3 Study of Givosiran, an Investigational RNAi https://t.co/oqUXU1ohLk August 21st 2018, 11:08am |
|
@MaisaCorp $ALNY Veristat Congratulates Alnylam on the FDA Approval of ONPATTRO(TM) (patisiran) August 20th 2018, 4:08pm |
 |
@CarlyHFierce ICYMI: Alnylam vows value-based pricing, financial help with $450K Onpattro launch https://t.co/t38oJvPEH5 $ALNY #pharma August 20th 2018, 3:08pm |
 |
@AmericanBanking Weekly Analysts’ Ratings Updates for Alnylam Pharmaceuticals $ALNY https://t.co/sCavb2A8YF #stocks August 20th 2018, 7:08am |
 |
@TranscriptDaily Weekly Analysts’ Ratings Updates for Alnylam Pharmaceuticals $ALNY https://t.co/jUFEXwPRV8 August 20th 2018, 7:08am |
 |
@RNAiAnalyst $SLN stock up 17%...settlement in $ALNY to be announced on official EU approval? https://t.co/x9bnHAjsBZ August 20th 2018, 7:08am |
 |
@tgtxdough GS ESC CONFERENCE. 8/28. Focus is high on $PFE’s Tafamadis data&competitive read-through to $ALNY while we&others s… https://t.co/VacNaeRWcQ August 19th 2018, 10:08pm |
 |
@jbzstocks $ALNY -- Textbook stochastic divergence. Seems like a good time to breakout of the 20+ week base. https://t.co/aeNn1geKgx August 19th 2018, 1:08pm |
 |
@beyond_ninety Alnylam Pharmaceuticals $ALNY Shares Declined While Sabby Management Has Cut Position; Expeditors Intl $EXPD Holder… https://t.co/B8JwUZ6yC2 August 19th 2018, 12:08pm |
|
@MareaInformativ Alnylam Pharmaceuticals $ALNY Given New $99.00 Price Target at Morgan Stanley https://t.co/nNc38RzDpo August 19th 2018, 12:08pm |
|
@usindexlive Thornburg Investment Management Has Lifted Cognizant Tech Solutions $CTSH Stake; Alnylam Pharmaceuticals $ALNY's Se… https://t.co/h345gE4Hi6 August 19th 2018, 8:08am |
 |
@themarketisopen $ALNY Here’s Why Alnylam’s Shares Are Tumbling https://t.co/dmu9WK4Eob August 18th 2018, 10:08pm |
|
@AmericanBanking Alnylam Pharmaceuticals, Inc. $ALNY Receives Average Recommendation of “Buy” from Brokerages https://t.co/BXv5gV1zI9 #stocks August 18th 2018, 4:08pm |
 |
@ConsumerFeed Alnylam Pharmaceuticals, Inc. $ALNY Receives Average Recommendation of “Buy” from Brokerages https://t.co/gtd872cOor August 18th 2018, 4:08pm |
|
@usindexlive Alnylam Pharmaceuticals $ALNY Shares Declined While Eventide Asset Management Has Trimmed Its Holding by $3.33 Mill… https://t.co/QiCC90OjA3 August 18th 2018, 11:08am |
|
@themarketisopen $ALNY Here’s Why Alnylam’s Shares Are Tumbling https://t.co/93oFm4lVaB August 18th 2018, 7:08am |
 |
@WeekHerald Q3 2018 Earnings Forecast for Alnylam Pharmaceuticals, Inc. Issued By Piper Jaffray Companies $ALNY https://t.co/3CPbbU6OqC August 18th 2018, 1:08am |
 |
@ThisLincolnian Q3 2018 Earnings Forecast for Alnylam Pharmaceuticals, Inc. Issued By Piper Jaffray Companies $ALNY https://t.co/07iOe54Agv August 18th 2018, 1:08am |
|
@TranscriptDaily Zacks: Brokerages Anticipate Alnylam Pharmaceuticals, Inc. $ALNY Will Post Earnings of -$1.78 Per Share https://t.co/EhT7AhPagE August 17th 2018, 9:08pm |
 |
@ZolmaxNews Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY Will Announce Quarterly Sales of $20.00 Million https://t.co/ODJIvIMTHc August 17th 2018, 9:08pm |
 |
@psuvafan007 Using $ALNY patisirin RNAi timeline as comparision, will first CRISPR drug gain approval faster or slower than 20 y… https://t.co/DmQZbP23hA August 17th 2018, 11:08am |
|
@beyond_ninety As Alnylam Pharmaceuticals Com $ALNY Stock Value Declined, Holder Canada Pension Plan Investment Board Has Decrease… https://t.co/Qyf9JLVgUQ August 17th 2018, 10:08am |
|
@TRiMBio1 @BagholderQuotes I got a bad case of the tutes, damn it $ALNY August 17th 2018, 10:08am |
 |
@portefeuillefun Sold 100 $ALNY at $94.08, now 700 #vssporte shares. August 17th 2018, 9:08am |
|
@RNAiAnalyst 2ndary outcomes for disease progression/reversal could have most impact on $alny https://t.co/JreEDcTBF2 August 17th 2018, 9:08am |
|
@WeekHerald Alnylam Pharmaceuticals $ALNY Stock Rating Lowered by Goldman Sachs Group https://t.co/1YqpPmL6vL August 17th 2018, 8:08am |
|
@dakotafinancial Stifel Nicolaus Reaffirms Buy Rating for Alnylam Pharmaceuticals $ALNY https://t.co/5SlIBbvkIS August 17th 2018, 8:08am |
|
@ThisLincolnian Alnylam Pharmaceuticals $ALNY Stock Rating Lowered by Goldman Sachs Group https://t.co/gkOhsS3EMv August 17th 2018, 8:08am |
|
@ZolmaxNews Alnylam Pharmaceuticals’ $ALNY Buy Rating Reaffirmed at Needham & Company LLC https://t.co/aLYiMmb5l7 August 17th 2018, 6:08am |
 |
@TheMarketsDaily B. Riley Increases Alnylam Pharmaceuticals $ALNY Price Target to $230.00 https://t.co/TKe85KBcbb August 17th 2018, 6:08am |
 |
@dailypoliticaln Morgan Stanley Analysts Give Alnylam Pharmaceuticals $ALNY a $93.00 Price Target https://t.co/mn1BYjshSR August 17th 2018, 6:08am |
|
@MareaInformativ BMO Capital Markets Trims Alnylam Pharmaceuticals $ALNY Target Price to $125.00 https://t.co/qVo150UPo0 August 17th 2018, 6:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.